Revisiting the Cholinergic Hypothesis in Alzheimer’s Disease: Emerging Evidence from Translational and Clinical Research Harald HampelM.-M. MesulamCholinergic System Working Group, and for the Alzheimer Precision Medicine Initiative (APMI) Point of View 19 October 2018 Pages: 2 - 15
Polygenic Risk Score Analysis of Alzheimer’s Disease in Cases without APOE4 or APOE2 Alleles V. Escott-PriceA. MyersJohn Hardy Original Research Open access 14 December 2018 Pages: 16 - 19
Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? Donna A. MessnerP. RabinsD. Wuest Original Research 19 October 2018 Pages: 20 - 26
Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms Clive BallardJ. M. YouakimS. Stankovic Original Research Open access 16 August 2018 Pages: 27 - 33
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer’s Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study V. Pérez-GrijalbaJ. RomeroThe AB255 Study Group Original Research 19 October 2018 Pages: 34 - 41
Treatable Vascular Risk and Cognitive Performance in Persons Aged 35 Years or Older: Longitudinal Study of Six Years Marlise E. A. van EerselH. JoostenG. J. Izaks Original Research Open access 14 December 2018 Pages: 42 - 49
Diet as a Risk Factor for Cognitive Decline in African Americans and Caucasians with a Parental History of Alzheimer’s Disease: A Cross-Sectional Pilot Study Dietary Patterns A. C. NutaitisS. D. TharwaniWhitney Wharton Original Research Open access 30 November 2018 Pages: 50 - 55
Increased Functional Connectivity After Listening to Favored Music in Adults With Alzheimer Dementia J. B. KingK. G. JonesN. L. Foster Original Research 07 May 2018 Pages: 56 - 62
AADvac1, an Active Immunotherapy for Alzheimer’s Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development P. NovakN. ZilkaM. Novak Review 14 December 2018 Pages: 63 - 69
Bifidobacterium Breve A1 Supplementation Improved Cognitive Decline in Older Adults with Mild Cognitive Impairment: An Open-Label, Single-Arm Study Yodai KobayashiT. KinoshitaJ.-Z. Xiao Short Communication 27 August 2018 Pages: 70 - 75